Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases.
about
Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3Low concentrations of methamphetamine can protect dopaminergic cells against a larger oxidative stress injury: mechanistic studyPlants and phytochemicals for Huntington's diseaseCharacterization of the stability and bio-functionality of tethered proteins on bioengineered scaffolds: implications for stem cell biology and tissue repair.Neuroprotective effects of active ingredients isolated from Pegasus laternarius on cultured cerebral neurons.Resveratrol attenuates oxidative stress and improves behaviour in 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice.Transplantation therapy for Parkinson's disease.Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of unilateral 6-hydroxydopamine induced Parkinson's rats: effect of 5-HT, GABA and bone marrow cell supplementation.Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.Neuroprotective effects of melittin on hydrogen peroxide-induced apoptotic cell death in neuroblastoma SH-SY5Y cellsAMP-activated protein kinase deficiency rescues paraquat-induced cardiac contractile dysfunction through an autophagy-dependent mechanismGlobus Pallidus Externus Neurons Expressing parvalbumin Interconnect the Subthalamic Nucleus and Striatal Interneurons.Prophylactic activation of neuroprotective stress response pathways by dietary and behavioral manipulationsEffect of exercise on diabetes-induced oxidative stress in the rat hippocampus.Amlodipine, an L-type calcium channel blocker, protects against chlorpromazine-induced neurobehavioural deficits in mice.Neurochemical targets and behavioral effects of organohalogen compounds: an update.Akt attenuates apoptotic death through phosphorylation of H2A under hydrogen peroxide-induced oxidative stress in PC12 cells and hippocampal neurons.The X-linked adrenoleukodystrophy (X-ALD) and oxidative stress.Hydroxysafflor yellow A exerts antioxidant effects in a rat model of traumatic brain injury.The DNA-PK catalytic subunit regulates Bax-mediated excitotoxic cell death by Ku70 phosphorylation.The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's diseaseBiofunctionalisation of polymeric scaffolds for neural tissue engineering.Human olfactory bulb neural stem cells mitigate movement disorders in a rat model of Parkinson's disease.Cell Therapy in Parkinson's Disease: Host Brain Repair Machinery Gets a Boost From Stem Cell Grafts.Chikusetsu saponin V attenuates H2O2-induced oxidative stress in human neuroblastoma SH-SY5Y cells through Sirt1/PGC-1α/Mn-SOD signaling pathways.Effects of GDNF-loaded injectable gelatin-based hydrogels on endogenous neural progenitor cell migration.Mechanisms of MPP⁺-induced PC12 cell apoptosis via reactive oxygen species.Glutamatergic excitation and GABA release from a transplantable cell line.Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells.Protective effect of augmenter of liver regeneration on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells.Brain-derived neurotrophic factor prevents changes in Bcl-2 family members and caspase-3 activation induced by excitotoxicity in the striatum.Size-Dependent Toxicity Differences of Intratracheally Instilled Manganese Oxide Nanoparticles: Conclusions of a Subacute Animal Experiment.Adenosine as a neuroprotectant: therapeutic perspectives.Striatopallidal neurons are selectively protected by neurturin in an excitotoxic model of Huntington's disease.Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members.Cardiac-Specific Knockout of ETA Receptor Mitigates Paraquat-Induced Cardiac Contractile Dysfunction.Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury.Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study.Protective activity of aromatic amines and imines against oxidative nerve cell death.Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome.
P2860
Q28348876-0861DD74-049A-48F8-BD21-02066462AA64Q28477457-C31EA254-05B4-470F-82A3-06E1657608A8Q28661435-20E43D29-D219-4993-83AF-C22A0BDF02E7Q33652222-6F7E6B1E-4231-4FDC-BB7E-2FB95D6EF687Q33670809-2F11EDE1-35A0-4D81-A363-78FB8A23726FQ33979340-A49ED51D-8BD1-426F-9C76-6949CAE32948Q34075118-DC38306C-6A95-4BBC-8EC7-D5A30575A586Q34521827-1FC05016-83F4-4664-A829-EEABAA086A78Q34523361-D2C635EC-E910-4420-8205-1B173570A309Q34582215-64A1584B-B6C2-44DF-86C4-875231F36DF9Q35102608-EC8A3700-EFD2-455F-AB34-1D3C39AB6545Q35932231-CE91929C-76E2-44E2-B4A4-8F89965B207FQ36045242-617722EE-2E70-49FA-949F-1EE82198BB2CQ36065540-398FFBF6-7586-472B-8B02-587E6C86706AQ36254230-DD2130B7-F758-457F-B7DE-36B3C8EEB694Q36473995-9F0A06F3-439A-49E1-A384-1633AFDB5503Q36602241-F152F172-0B0D-445D-BACA-2D100724A7A3Q36743396-5A46F5BD-0FEE-44E5-B632-7F421D18108FQ37297462-8608FEB7-3AED-4CB6-87FE-BE482DEAD379Q37366735-9E1B2E2C-7321-4CBD-820E-3E54B4FAA75BQ37845675-E55FD5CA-1D7B-4DF2-A31D-9518E580C573Q38001616-78CAD57A-BB33-4821-90DE-28E6D1CE09C1Q38302028-EAFD2D32-D64F-4A83-9269-1B3A413F8547Q38686736-F86CC666-72AF-4AD5-915A-AC7646F61FA2Q38762830-DC546EA8-672E-40AE-AD70-D1FD8F73FAD9Q39018479-D6E0ECA3-EA4C-4C98-936A-936722D233DFQ39220091-24D80745-C961-4C27-94EA-1B542247F424Q39689062-CDC68246-374C-4EFF-9E9F-70F166BCBAB3Q39741931-C7FC4D76-DB4B-4D4A-9EDC-7FF726C17E33Q39821234-08D6BC4F-93CB-46E9-B21C-8C7C30617EEDQ40469094-A581B94B-29EC-415B-92BD-8A3C2E79D033Q40524915-3E495201-0287-488E-A7E5-461DA34307EAQ40657295-0656431E-67AD-4377-B890-6FF3CABC9563Q40744948-BFE28C60-D152-4C56-BFC5-6A4DBE2B9238Q40777710-D6AFEB08-9EF8-42A6-B2D3-E44C3EF9242BQ41658073-152A6BFC-31C9-41D5-97E0-ADDAB6780EC7Q43104855-72D96A7E-49BE-45E9-BFA2-AF546D1BC92DQ43122795-7DE17AA3-B475-44E5-9334-AE18B990399FQ43840174-EB73D398-06C4-44DD-803D-A6329605FB8EQ43892580-9C851D81-54F7-4CB8-A71B-9B755F482469
P2860
Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Neuroprotective strategies for ...... n's and Huntington's diseases.
@ast
Neuroprotective strategies for ...... n's and Huntington's diseases.
@en
type
label
Neuroprotective strategies for ...... n's and Huntington's diseases.
@ast
Neuroprotective strategies for ...... n's and Huntington's diseases.
@en
prefLabel
Neuroprotective strategies for ...... n's and Huntington's diseases.
@ast
Neuroprotective strategies for ...... n's and Huntington's diseases.
@en
P2093
P1476
Neuroprotective strategies for ...... n's and Huntington's diseases.
@en
P2093
Borlongan CV
Gluckman PD
Williams CE
P304
P356
10.1016/S0301-0082(99)00032-5
P577
2000-04-01T00:00:00Z